Mason Street Advisors, LLC Abb Vie Inc. Transaction History

Mason Street Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $24.9 Million - $27.4 Million	-243,542 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $348,763 - $470,867	-4,333 Reduced 1.75%	243,542 $26.1 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $319,928 - $375,490	-3,724 Reduced 1.48%	247,875 $21.7 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.98 Million - $3.99 Million	40,605 Added 19.24%	251,599 $24.7 Million
Q4 2019 Feb 19, 2020	BUY	$72.13 - $90.25 $25,822 - $32,309	358 Added 0.17%	210,994 $18.7 Million
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $12,596 - $15,144	-200 Reduced 0.09%	210,636 $15.9 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $26,017 - $33,256	396 Added 0.19%	210,836 $15.3 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $125,892 - $148,169	-1,632 Reduced 0.77%	210,440 $17 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $62,435 - $77,000	-802 Reduced 0.38%	212,072 $19.6 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $22,049 - $24,512	248 Added 0.12%	212,874 $20.1 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $846,445 - $1 Million	-9,428 Reduced 4.25%	212,626 $19.7 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $920 - $1,232	10 Added 0.0%	222,054 $21 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $67,528 - $74,050	754 Added 0.34%	222,044 $21.5 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $15.5 Million - $19.7 Million	221,290	221,290 $19.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.